Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

ROSUVASTATIN FOR PEAK IDENTIFICATION CRS (15 MG)

ROSUVASTATIN FOR PEAK IDENTIFICATION CRS (15 MG)

ND

DISCOVER
SENNA EXTRACT HRS (25 MG)

SENNA EXTRACT HRS (25 MG)

ND

DISCOVER
MERCAPTOPURINE IMPURITY D CRS(15 MG)

MERCAPTOPURINE IMPURITY D CRS(15 MG)

ND

DISCOVER
TRANEXAMIC ACID IMPURITY F CRS (10 MG)

TRANEXAMIC ACID IMPURITY F CRS (10 MG)

ND

DISCOVER
TRANEXAMIC ACID IMPURITY C CRS (10 MG)

TRANEXAMIC ACID IMPURITY C CRS (10 MG)

ND

DISCOVER
TRANEXAMIC ACID IMPURITY B CRS (15 MG)

TRANEXAMIC ACID IMPURITY B CRS (15 MG)

ND

DISCOVER
EXEMESTANE FOR PEAK IDENTIFICATION CRS (10 MG)

EXEMESTANE FOR PEAK IDENTIFICATION CRS (10 MG)

ND

DISCOVER
FLUOCORTOLONE  PIVALATE FOR SYSTEM SUITABILITY CRS (10 MG)

FLUOCORTOLONE PIVALATE FOR SYSTEM SUITABILITY CRS (10 MG)

ND

DISCOVER
PYRANTEL IMPURITY C CRS (30 MG)

PYRANTEL IMPURITY C CRS (30 MG)

ND

DISCOVER
RHEIN CRS (25 MG)

RHEIN CRS (25 MG)

ND

DISCOVER
DONEPEZIL HYDROCHLORIDE CRS (50 MG)

DONEPEZIL HYDROCHLORIDE CRS (50 MG)

ND

DISCOVER
NOMEGESTROL ACETATE FOR ID AND ASSAY CRS (70 MG)

NOMEGESTROL ACETATE FOR ID AND ASSAY CRS (70 MG)

ND

DISCOVER